Tau gene mutations and tau pathology in frontotemporal dementia and parkinsonism linked to chromosome 17

Advances in Experimental Medicine and Biology

Volumn 487, Issue , 2001, Pages 21-37

  Spillantini, M G ^a   Goedert, M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

CHROMOSOME 17Q; CONFERENCE PAPER; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPATHOLOGY; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0034981507     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-1249-3_3     Document Type: Conference Paper

References (92)

1. Über die Beziehungen der senilen Himatrophie zur Aphasie
2. Über eigenartige Krankheitsfälle des Späteren Alters
3. Electron microscopic structure of the inclusion bodies in Pick's disease
4. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein tau
5. Pick's disease: Hyperphosphorylated tau segregates to the somatoaxonal compartment
6. Über eine eigenartige Erkrankung der Hirnrinde
7. Tau protein pathology in neurodegenerative diseases Trends Neurosci
8. Localization of disinhibitiondementia-parkinsonism-amyotrophy complex to 17q21-q22
9. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus statement
10. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies
11. Tau is a candidate gene for chromosome 17 frontotemporal dementia
12. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
13. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
14. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer's disease
15. Cloning and sequencing of the cDNA encoding an isoform of microtubule associated protein tau containing four tandem repeats; differential expression of tau protein mRNAs in human brain
16. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
17. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization
18. Structure and novel exons of the human tau gene
19. Domains of tau protein and interaction with microtubules
20. Identification of a novel microtubule-binding and assembly domain in the developmentally regulated inter-repeat region of tau
21. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism
22. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
23. High prevalence of mutations in the microtubule associated protein tau in a population study of frontotemporal dementia in the Netherlands
24. A distinct familial presenile dementia with a novel missense mutation in the tau gene
25. Mutations in the tau exon 10 splice site region in familial frontotemporal dementia
26. Tau gene mutation in familial progressive subcortical gliosis
27. Tau pathology in a family with dementia and a P301L mutation in tau
28. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
29. Missense and silent tau gene mutations cause frontotemporal dementia and parkinsonism - Chromosome 17, by affecting multiple alternative RNA splicing regulatory elements
30. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in Tau
31. From genotype to phenotype: A clinical, pathological and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
32. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy
33. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia
34. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke family 1684
35. A mutation in the microtubuleassociated protein tau in pallido-nigro-luysian degeneration
36. Phenotypic variation in hereditary frontotemporal dementia with tau mutations
37. FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation
38. Tau gene mutation G389R causes a tauopathy with abundant Pick body-like inclusions and axonal deposits
39. A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)
40. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene. Expansion of the disease phenotype caused by tau gene mutations
41. Mutation specific functional impairments in distinct tau isoforms of hereditary FTDP-17
42. A new case of frontotemporal dementia and parkinsonism resulting from an intron 10+3-splice site mutation in the tau gene: Clinical and pathological features
43. Tau gene mutation K257T causes a tauopathy similar to Pick's disease
44. A novel Tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies
45. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
46. Mutations in tau reduce its microtubule binding properties in intact cells and affects its phosphorylation
47. Missense tau mutations identified in FTDP- 17 have a small effect on tau microtubule interactions
48. Accelerated filaments formation from tau protein with specific FTDP- 17 mutations
49. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments
50. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
51. 5′ Splice site mutations in tau associated with the inherited dementia FTDP- 17 affect a stem loop structure that regulates alternative splicing of exon 10
52. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia
53. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17
54. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics
55. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
56. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion
57. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
58. Tau mutations cause frontotemporal dementias
59. Tau pathology in two Dutch families with tau mutations in the microtubule binding region of tau
60. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
61. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles
62. Presence of two different fibril subtypes in the Pick body: An immunoelectron microscopic study
63. Immunohistochemical and ultrastructural studies of Pick's disease
64. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
65. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
66. Tau in paired helical filament is functionally distinct from fetal tau: Assembly incompetence of paired helical filament tau
67. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
68. Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interactions
69. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments
70. Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation and filament assembly depend on the degree of sulfation
71. A nucleated assembly mechanism of Alzheimer paired helical filaments
72. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease
73. Structural aspects of pathology in Alzheimer's disease
74. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type
75. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration
76. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively "exon 10" isoforms
77. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
78. Genetic evidence for the involvement of tau in progressive supranuclear palsy
79. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
80. Specifc pathological tau protein variants characterize Pick's disease
81. Vulnerable subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation
82. Engineering protein kinases with distinct nucleotide specificities and inhibitor sensitivities by mutation of a single amino acid
83. A GSK3-binding peptide from FRATI selectively inhibits GSK3-catalysed phosphorylation of axin and β-catenin
84. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
85. Phosphorylated tau can promote tubulin assembly
86. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
87. Transgenic expression of the shortest tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
88. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
89. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
90. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
91. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes
92. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein